Abstract:This work aimed to isolate, and identify Lactic Acid Bacteria LAB from Egyptian immature citrus honey, and characterize their secondary metabolites, as well as determine the antibacterial activities and transcription of virulence genes (stx1, stx2, and eae) influenced by these bacterial secondary metabolites. From twenty hives, twenty immature citrus bee honey samples were taken. Traditional cultural and biochemical testing were used, followed by molecular confirmation. Further, LAB isolates' antibacterial and cytotoxic properties were investigated. 16S rRNA gene sequencing were assessed and, two lactic acid bacterial isolates were identified as Lactobacillus acidophilus Ch 2 and Levilactobacillus brevis Ch 1 . Both isolates have good antagonistic action against clinical pathogens, with Levilactobacillus brevis Ch 1 exhibiting the best antibacterial activity against all indicator pathogens examined. When compared to untreated cancer cells, the isolates demonstrated significant cytotoxic activity. Ch 1 and Ch 2 cell viability percentages were 39.5% and 18.76%, respectively. Furthermore, when exposed to Levilactobacillus brevis Ch 1 metabolites, Shiga-producing Escherichia coli (STEC) virulence gene expression was suppressed. To identify bacterial secondary metabolites, a high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (HPLC-QTOF) approach was developed. Twenty-seven metabolites from diverse chemical classes were discovered in the crude extracts with antibacterial and anticancer characteristics. This is the first thorough investigation on the metabolic profile of LAB isolated from immature Egyptian honey and the findings suggested that isolates or their secondary metabolites could be used in the food sector as medicinal alternatives or as a biocontrol agent.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are: 1. **Isolation and identification of lactic acid bacteria from immature citrus honey in Egypt**: The research aims to isolate lactic acid bacteria (LAB) from immature citrus honey in Egypt and identify them. 2. **Characterization of secondary metabolites of lactic acid bacteria**: The research further characterizes the secondary metabolites of these lactic acid bacteria and explores the antibacterial activity of these metabolites against human pathogens. 3. **Evaluation of the effect of secondary metabolites on the transcription of pathogen virulence genes**: The research also evaluates the effect of these secondary metabolites on the transcription of virulence genes (such as stx1, stx2 and eae) of Shiga toxin - producing Escherichia coli (STEC). 4. **Evaluation of the cytotoxicity of secondary metabolites**: The research evaluates the cytotoxic effect of these secondary metabolites on human lung adenocarcinoma cell line A549. 5. **Identification of secondary metabolites by HPLC - QTOF mass spectrometry**: The research uses high - performance liquid chromatography - quadrupole time - of - flight mass spectrometry (HPLC - QTOF) technology to identify the secondary metabolites produced by these lactic acid bacteria. Specifically, the research found that: - Two lactic acid bacteria, namely Levilactobacillus brevis Ch1 and Lactobacillus acidophilus Ch2, were isolated from 20 immature citrus honey samples collected from 20 beehives. - The secondary metabolites of these two lactic acid bacteria have significant antibacterial activity against a variety of clinical pathogens, especially Levilactobacillus brevis Ch1 shows the strongest antibacterial effect. - The secondary metabolites have a significant cytotoxic effect on the A549 lung adenocarcinoma cell line. The cell survival rate of Levilactobacillus brevis Ch1 is only 39.5%, while that of Lactobacillus acidophilus Ch2 is 18.76%. - The secondary metabolites of Levilactobacillus brevis Ch1 can significantly inhibit the expression of virulence genes (stx1, stx2 and eae) of STEC. - Through HPLC - QTOF mass spectrometry analysis, 27 secondary metabolites with antibacterial and anticancer properties were identified, including steroids, phospholipids, hopanes, triglycerides and alkylamine derivatives, etc. These findings indicate that lactic acid bacteria in immature citrus honey and their secondary metabolites have potential application values in the food industry and the medical field, especially in the development of new antibacterial agents and anticancer drugs.

The Influence of Lactobacillus spp. Secondary Metabolites Isolated from Immature Egyptian Honey on Human Pathogens, Transcription of Virulence Genes and Lung Cancer

Characterization of Lactic Acid Bacteria Strains Isolated from Algerian Honeybee and Honey and Exploration of Their Potential Probiotic and Functional Features for Human Use

Antineoplastic with DNA fragmentation assay and anti-oxidant, anti-inflammatory with gene expression activity of Lactobacillus plantarum isolated from local Egyptian milk products

Coculture of bacterial levans and evaluation of its anti-cancer activity against hepatocellular carcinoma cell lines

Antibacterial effects of Apis mellifera and stingless bees honeys on susceptible and resistant strains of Escherichia coli, Staphylococcus aureus and Klebsiella pneumoniae in Gondar, Northwest Ethiopia

Bioactive metabolites from autochthonous lactic acid bacteria inhibit the growth of Melissococcus plutonius, causal agent of European foulbrood disease in honey bees

Antimicrobial Properties, Functional Characterisation and Application of Fructobacillus fructosus and Lactiplantibacillus plantarum Isolated from Artisanal Honey

Probiotic Potential and Effects on Gut Microbiota Composition and Immunity of Indigenous Gut Lactobacilli in Apis cerana

GC-MS analysis of honeybee products derived from medicinal plants

Characterization and Protective Properties of Lactic Acid Bacteria Intended to Be Used in Probiotic Preparation for Honeybees (Apis mellifera L.)—An In Vitro Study

New insights into changing honey bee (Apis mellifera) immunity molecules pattern and fatty acid esters, in responses to Ascosphaera apis infection

Evaluation of Egyptian honeys and their floral origins: phenolic compounds, antioxidant activities, and antimicrobial characteristics

Chemical Profiling and Nutritional Evaluation of Bee Pollen, Bee Bread, and Royal Jelly and Their Role in Functional Fermented Dairy Products

Assessment of exopolysaccharides, bacteriocins and in vitro and in vivo hypocholesterolemic potential of some Egyptian Lactobacillus spp.

Antibacterial Activity and Prebiotic Properties of Six Types of Lamiaceae Honey

Comprehensive analysis of the microbiome in Apis cerana honey highlights honey as a potential source for the isolation of beneficial bacterial strains

Method validation and risk assessment for sulfonamides and tetracyclines in bees’ honey from Egypt, Libya and Saudi Arabia

Diversity and antibacterial potential of the Actinobacteria associated with Apis mellifera ligustica

Impact of a novel probiotic Lactobacillus strain isolated from the bee gut on GABA content, antioxidant activity, and potential cytotoxic activity against HT-29 cell line of rice bran

Functional products fortified with probiotic LAB isolated from Egyptian dairy sources showed hypolipidemic effects in Albino rats

Stingless Bee Honey: Evaluating Its Antibacterial Activity and Bacterial Diversity